Cellosaurus logo
expasy logo

Cellosaurus BID019 (CVCL_E6DY)

[Text version]
Cell line name BID019
Synonyms Beth Israel Deaconess 019
Accession CVCL_E6DY
Resource Identification Initiative To cite this cell line use: BID019 (RRID:CVCL_E6DY)
Comments Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
Sequence variations
  • Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Asn771_His772insHis; Zygosity=Unspecified (PubMed=31467113).
Disease Lung adenocarcinoma (NCIt: C3512)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Category Cancer cell line
Publications

PubMed=31467113; DOI=10.1158/1541-7786.MCR-19-0419; PMCID=PMC6872223
Udagawa H., Hasako S., Ohashi A., Fujioka R., Hakozaki Y., Shibuya M., Abe N., Komori T., Haruma T., Terasaka M., Fujita R., Hashimoto A., Funabashi K., Yasuda H., Miyadera K., Goto K., Costa D.B., Kobayashi S.S.
TAS6417/CLN-081 is a pan-mutation-selective EGFR tyrosine kinase inhibitor with a broad spectrum of preclinical activity against clinically relevant EGFR mutations.
Mol. Cancer Res. 17:2233-2243(2019)

Entry history
Entry creation10-Apr-2025
Last entry update10-Apr-2025
Version number1